R X Innovations Of America Inc is categorized under Wholesale Pharmaceutical Products in Chicago, IL and active since 2004.
R X Innovations Of America Inc was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Mark E Mlotek at the company’s single location by writing to 77 East Monroe St # 420, Chicago, Illinois IL 60603 or by phoning (918) 786-3221. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | R X Innovations Of America Inc |
Contact Person: | Mark E Mlotek |
Address: | 77 East Monroe St # 420, Chicago, Illinois 60603 |
Phone Number: | (918) 786-3221 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2004 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Wholesale Pharmaceutical Products |
SIC Code: | 5122 |
NAICS Code: | 424210 |
Share This Business: |
R X Innovations Of America Inc was started in 2004 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Mark E Mlotek for inquiries that concern R X Innovations Of America Inc by calling the company number (918) 786-3221, as your correspondence is most welcome. Additionally, the physical location of the single location of R X Innovations Of America Inc can be found at the coordinates as well as the street address 77 East Monroe St # 420 in Chicago, Illinois 60603.
For its online presence, you may visit R X Innovations Of America Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.